Definium Therapeutics, Inc. (DFTX)
44.81
+1.54
(+3.56%)
USD |
NASDAQ |
Aug 25, 16:00
44.74
-0.07
(-0.16%)
After-Hours: 19:59
Definium Therapeutics Shareholders Equity (Quarterly) : 918.68M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 918.68M |
| March 31, 2026 | 278.85M |
| December 31, 2025 | 332.33M |
| September 30, 2025 | 130.60M |
| June 30, 2025 | 185.40M |
| March 31, 2025 | 222.81M |
| December 31, 2024 | 241.45M |
| September 30, 2024 | 262.19M |
| June 30, 2024 | 202.05M |
| March 31, 2024 | 196.06M |
| December 31, 2023 | 78.13M |
| September 30, 2023 | 95.98M |
| June 30, 2023 | 105.97M |
| March 31, 2023 | 130.34M |
| December 31, 2022 | 150.92M |
| September 30, 2022 | 153.59M |
| June 30, 2022 | 124.50M |
| March 31, 2022 | 136.80M |
| December 31, 2021 | 151.66M |
| Date | Value |
|---|---|
| September 30, 2021 | 166.05M |
| June 30, 2021 | 151.66M |
| March 31, 2021 | 187.59M |
| December 31, 2020 | 83.27M |
| September 30, 2020 | 19.64M |
| June 30, 2020 | 27.74M |
| March 31, 2020 | 23.84M |
| August 31, 2019 | 2.738M |
| May 31, 2019 | 3.402M |
| February 28, 2019 | 3.524M |
| November 30, 2018 | 3.396M |
| August 31, 2018 | 3.525M |
| May 31, 2018 | 3.252M |
| February 28, 2018 | 3.481M |
| November 30, 2017 | 3.677M |
| August 31, 2017 | 3.571M |
| May 31, 2017 | 3.811M |
| February 28, 2017 | 2.19M |
| November 30, 2016 | 0.7559M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 1.044M |
| CNBX Pharmaceuticals, Inc. | -2.660M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 562.20M |
| Fulcrum Therapeutics, Inc. | 310.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.113B |
| Total Liabilities (Quarterly) | 194.22M |
| Debt to Equity Ratio | 0.0397 |
| Current Ratio | 6.947 |
| Net Debt Paydown Yield | -0.05% |